AGF INVESTMENTS INC. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
AGF INVESTMENTS INC. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2021$385,000
+84.2%
4,488
+72.6%
0.00%
+50.0%
Q3 2021$209,000
+21.5%
2,600
+21.8%
0.00%
+100.0%
Q2 2021$172,000
-8.5%
2,134
-4.4%
0.00%0.0%
Q1 2021$188,000
-9.6%
2,232
-14.0%
0.00%
-50.0%
Q4 2020$208,000
-66.0%
2,595
-65.9%
0.00%
-66.7%
Q3 2020$612,000
-56.6%
7,607
-53.6%
0.01%
-60.0%
Q2 2020$1,411,000
-16.8%
16,386
-21.5%
0.02%
-28.6%
Q1 2020$1,695,000
-88.1%
20,879
-89.8%
0.02%
-86.4%
Q2 2015$14,231,000
+8.6%
203,900
+6.6%
0.15%
+8.5%
Q1 2015$13,101,000
-38.6%
191,300
-34.3%
0.14%
-37.7%
Q4 2014$21,325,000
-2.1%
291,300
-3.9%
0.23%
+0.4%
Q3 2014$21,791,000
-0.6%
303,1000.0%0.23%
+5.6%
Q2 2014$21,923,000
-1.7%
303,1000.0%0.22%
-5.3%
Q1 2014$22,304,000
+0.5%
303,100
-5.0%
0.23%0.0%
Q4 2013$22,202,000
+180.4%
318,900
+164.0%
0.23%
+155.1%
Q3 2013$7,917,000120,8000.09%
Other shareholders
BAXTER INTL INC shareholders Q3 2015
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders